Overexpression of SV40 T-antigen (SV40 T-Ag) has been widely used to overcome replicative senescence of human primary cells and to promote cell immortalization. However, in the case of certain cell types, such as preadipocytes, the differentiation process of immortalized cells is blocked by SV40 T-Ag expression. In this study, human telomerase reverse transcriptase (hTERT) and papillomavirus E7 oncoprotein (HPV-E7) genes were coexpressed in human preadipocytes to test whether this combination could maintain cell differentiation capacity after immortalization. We demonstrated that the HPV-E7/hTERT expressing preadipocytes displayed an indefinite life span. Interestingly, immortalized cells were diploid and presented no chromosomic alterations. These immortalized cells were able to accumulate and hydrolyze intracellular triglycerides and to express adipocyte markers. These data demonstrate, for the first time, that coexpression of hTERT and HPV-E7 in human preadipocytes allows cells not only to display an indefinite life span but also to retain their capacity to differentiate.
Introduction
Proliferation of primary cells is limited to a few population doublings (PDs) before entering into a phase of growth arrest called replicative senescence. Overexpression of viral oncogenes such as the SV40 T-antigen (SV40 T-Ag) has been widely used to overcome senescence and promote human cell immortalization. 1 However, ectopic expression of viral oncogenes allows primary cells to overcome replicative senescence, only for a few PDs before entering into a second nonreplicative phase called 'crisis'. 2 In most cell types, rare cellular clones are able to escape from crisis and to proliferate indefinitely. 3 This limitation in the immortalization process of human cells can be overcome by the reconstitution of the telomerase activity. Indeed, it has been recently shown that overexpression of the human telomerase reverse transcriptase (h-TERT) allows SV40 T-Ag-transformed cells, derived from different tissues, to bypass the crisis step and to promote indefinite life span. 4, 5 Nevertheless, the differentiation process of certain cell types, such as preadipocytes, is clearly blocked by SV40 T-Ag expression. 6 Differentiation of preadipocytes into adipocytes (i.e. adipogenesis) is a well-described system regulated by various factors. The adipocyte differentiation cascade is controlled by two key transcriptional factors: the peroxisome proliferatoractivated receptor gamma (PPARg) and the CCAAT/enhancer binding protein alpha (C/EBPa). The cAMP-response element-binding protein (CEBP) and its highly related p300 protein have been recently shown to be necessary for the induction of both PPARg and C/EBPa. 7 Interestingly, SV40 TAg interacts with both CBP and p300, inhibiting their coactivation function. 8 These observations could explain why a previous attempt to immortalize human preadipocytes derived from white adipose tissue with SV40 T-Ag has failed to deliver permanent cell lines showing a preserved capacity for differentiation. 9 The E7 oncoprotein from the human papillomavirus type 16 (HPV-E7) has also been reported as a factor promoting human cell immortalization. 10 However, immortalization by HPV-E7 alone is a rare event. Coexpression of HPV-E7 and hTERT was shown to increase the frequency of immortalization of human keratinocytes. 11 Interestingly, unlike SV40 TAg, HPV-E7 does not bind to CBP/p300, 12 suggesting that overexpression of HPV-E7 in human preadipocytes could preserve their adipogenic capacity.
In this context, we tested whether ectopic expression of HPV-E7 combined with the reconstitution of telomerase activity would allow establishment of a human white preadipose cell line with an indefine life span and a preserved adipogenic capacity. For this purpose, human preadipocytes from subcutaneous white adipose tissue were successively infected with recombinant viruses carrying hTERT and HPV-E7 genes. We showed that these transformed cells were able to proliferate indefinitely and to differentiate into lipid-filled cells expressing adipocyte markers.
Results

Immortalization of human preadipocytes
Human primary preadipocytes were infected with a recombinant retrovirus carrying the hTERT gene. Several clones were obtained after histidinol selection. These cells were able to divide until about passage 12 before entering to senescence and growth arrest (not shown). The clone presenting the best capacity to accumulate lipid was infected at passage 8 with retroviral particles containing the HPV-E7 gene. After infection, cells started to proliferate more rapidly than cells infected with hTERT alone. These cells were able to grow with a doubling time of 45.670.8 h, without any modifications in cell proliferation, until at least 176 PDs (passage 46). This cell line considered as immortal was named Chub-S7. Chub-S7 cells expressed HPV-E7 gene as detected by reverse transcription-polymeral chain reaction (RT-PCR) (data not shown). Cells presented a telomerase activity (Figure 1a) , which was maintained until, at least, 145 PDs (passage 38; not shown). As expected, this activity was inhibited when cell lysates were either treated with RNAse or heated ( Figure 1a ).
Karyotype analysis
The chromosome pattern of Chub-S7 cells, analyzed at 96 and 156 PDs (passages 25 and 41, respectively), showed that cells were diploid with 46, XX chromosomes (Figure 1b) . Chromosomes did not present any apparent abnormalities at low and high passages.
Differentiation capacity of Chub-S7 cells
To determine whether Chub-S7 cells were able to differentiate, the expression of adipocyte markers was assessed, by real-time RT-PCR, at different time points during cellular maturation induced by a PPARg agonist, the BRL49653. These markers included (i) transcriptional factors involved in adipogenesis such a PPARg and C/EBPa, (ii) genes involved in lipid metabolism such as lipoprotein lipase (LPL) and adipocyte fatty acid binding protein (aP2), and finally (iii) adipocyte secreted factors such as adipsin and leptin.
Under basal conditions, PPARg was increased by about 10-fold at day 3 as compared to day 0 and remained constant until day 17. After incubation with dexamethasone (Dex) plus IBMX, PPARg mRNA was increased by about 45-fold at day 3 as compared to day 0 (Figure 2a) . After IBMX removal, PPARg mRNA fell to the basal level, but BRL49653 was able to reinitiate PPARg expression at days 10 and 17. In the presence of BRL49653, C/EBPa mRNA was slightly increased as early as day 6 after confluency and reached a plateau at day 13 ( Figure 2a) . The expression pattern of PPARg and C/EBPa genes, during Chub-S7 cell differentiation, was confirmed by Western-blot analysis. As shown in Figure 2b , the expression of both proteins was time dependent with a maximum level observed at day 17.
Cells cultured in the presence of the PPARg agonist showed increased levels of aP2 and LPL mRNA as early as days 3 and 6 after confluency, respectively ( Figure 3 ). This expression continued to increase up to day 17 for both genes. Dex alone was able to enhance aP2 and LPL mRNA expression significantly at day 17 as compared to day 0, but to a lesser extent to that observed in the presence of the PPARg agonist (5 versus 5400-fold increase for aP2 and 8 versus 150-fold increase for LPL). Adipsin mRNA levels reached a plateau as early as day 10, whereas the highest leptin mRNA expression was observed only at day 17 ( Figure 3 ). Before day 17, the increase in leptin mRNA was similar in the presence or absence of the PPARg agonist but was two-fold higher at day 17 in the presence of BRL49653 when compared to Dex alone. The expression of the ribosomal protein large P0 (RPLpO) used in this study for normalization showed no changes in mRNA levels during Chub-S7 cell differentiation ( Figure 3 ).
These results show that under conventional serum-free culture conditions, differentiated Chub-S7 cells were able to acquire the main adipocyte markers.
Functional characteristics of differentiated Chub-S7 cells
To study the ability of differentiated Chub-S7 cells to accumulate intracellular lipids, cells cultured for 17 days in the absence or presence of BRL49653 were fixed and stained with Oil-red O. Almost all the differentiated cells were able to accumulate at least one single lipid droplet and few of them presented large multilocular droplets (Figure 4a ). When oleic acid (OA) (100 mM complexed with BSA) was added from days 10 to 17 to the differentiation medium containing BRL49653, Chub-S7 cells showed a dramatic increase in their triglyceride content with large multilocular lipid droplets (Figure 4a ). The presence of OA did not affect the expression of LPL, C/EBPa, aP2, leptin and adipsin induced by BRL49653 (data not shown).
Lipolytic capacity of differentiated cells was assessed by measuring glycerol release, after stimulation or not for 1 h with 1 mM isoproterenol (Iso), a nonspecific b-adrenergic agonist. Cells were differentiated in the presence of BRL49653 alone. Iso significantly increased by 40.5% lipolysis in cells cultured in the presence of the PPARg agonist (Figure 4b) .
The glycerol-3-phosphate dehydrogenase (GPDH) is a key enzyme involved in the glycerol phosphate shuttle pathway. Its activity was measured in Chub-S7 cells during differentiation. Figure 4c shows that GPDH-specific activity was slightly increased, at day 10, in the presence of BRL49653 and reached a maximum level at day 17. Under basal conditions or with Dex alone, GPDH specific activity was not increased along the time course (Figure 4c ).
Discussion
SV40 T-Ag, a well-known immortalizing factor, has been shown to alter cell differentiation and especially to block the maturation of preadipocytes into adipocytes. 6 This inhibitory effect of SV40 T-Ag could explain the limited differentiation capacity of the SV40 T-Ag-transformed human white preadipocytes described previously. 9 In this study, we demonstrate, for the first time, that co-expression of hTERT and HPV-E7 in human preadipocytes allows cells not only to display an indefinite life span but also to retain their features of primary cells. The immortalized Chub-S7 cells displayed a comparable proliferation rate and a similar doubling time to human primary stromal cells, 13 suggesting a limited deregulation of cell cycle checkpoints. In the presence of fatty acids, the differentiated Chub-S7 cells were able to accumulate large lipid droplets, indicating a preserved capacity to synthesize triglycerides. On the other hand, when Chub-S7 cells were differentiated in the presence of carbohydrates as a unique substrate for triglyceride synthesis, a reduced lipid droplet accumulation was observed. Interestingly, HPV-E7 was described to inhibit pyruvate kinase, a rate-limiting enzyme of the glycolytic pathway.
14 This HPV-E7 property could explain the limited capacity of Chub-S7 cells to synthetize lipids from glucose (i.e. de novo lipogenesis). Nevertheless, in human adipose tissue, lipogenesis is a minor pathway for triglyceride synthesis as compared to fatty acid esterification, 15 indicating that Chub-S7 cell metabolism is close to the in vivo situation. Finally, the lipid filled Chub-S7 cells were able to hydrolyze intracellular triglycerides under basal or stimulated conditions by a b-adrenergic receptor agonist, indicating a functional lipolytic activity.
The preserved phenotype observed in Chub-S7 cells when compared to SV40 T-Ag expressing human or mouse white preadipocytes 6, 9 could be explained by differences in the (i) genomic stability and/or (ii) interaction of the viral oncogenes with adipogenic factors. (i) The chromosomal aberrations, generally observed in immortalized cells, 16 can be responsible for important phenotypic changes. Cytogenic analysis showed that Chub-S7 cells retained a remarkable diploid feature without apparent chromosome aberrations, even at high passages. The fact that hTERT was introduced first in the human preadipocytes, which were later transformed with HPV-E7, may have positively influenced the genomic stability of Chub-S7 cells. The function of telomerase on telomere maintenance that protects chromosomes from exonucleolytic degradation could account for the genomic stability 17 and preserved phenotype observed in Chub-S7 cells. This has been previously demonstrated in mammary fibroblasts where the introduction of hTERT first and then SV40-T Ag yielded diploid cell lines, whereas introduction of hTERT late after the viral oncogene induced aneuploidy. 18 (ii) Viral oncogenes are known to interact with different cell cycle proteins such as the tumor suppressor protein p53 and retinoblastoma protein (pRb) family, including pRb, p107 and p300 members. SV40 T-Ag, but not HPV-E7, inactivates p53, while both viral oncogenes have been reported to interact with the pRb family. 19 Among this protein family, pRb inactivation but not p107 was reported to block adipocyte differentiation. 20 The fact that Chub-S7 cells retained the capacity to differentiate can be explained by the greater binding of HPV-E7 on p107 than pRb, whereas SV40 T-Ag interacts equivocally with pRb, p107, and p130. 21 This hypothesis is reinforced by the observation that unlike mouse preadipocytes lacking pRb, 20 C/EBPa gene, an important transcription factor involved in the process of adipocyte differentiation, was expressed during Chub-S7 cell differentiation. Finally, another pathway, than those involving the pRb family, could explain the preserved adipogenic capacity of Chub-S7 cells. As previously mentioned, unlike SV40 T-Ag, HPV-E7 does not interact with the CBP/p300 transcriptional complex, 12 which has been recently described to be necessary for the induction of both PPARg and C/EBPa. Owing to a higher replication rate of preadipocytes derived from massively obese subjects, 22 the use of adipocyte precursors from subcutaneous abdominal adipose tissue of a subject with a BMI of 54 kg/m 2 could have facilitated the immortalization process. Nevertheless, our immortalization strategy does not appear to be specific of fat depots, since we have recently obtained a preadipose cell line derived from omental adipose tissue of the same subject. These cells were able to grow until at least 60 PDs and preliminary data indicated a preserved phenotype and adipogenic capacity as observed in their subcutaneous counterparts, the Chub-S7 cells (data not shown).
In conclusion, we show that preadipocytes derived from human white adipose tissue preserved their adipogenic capacity after immortalization by hTERT and HPV-E7 coexpression. This approach allowed, for the first time, the establishment of a human white preadipose cell line, which represents a useful model for studying pharmacological and nutritional regulations of adipocyte differentiation and metabolism.
Materials and Methods
Materials
Cell culture media, fetal bovine serum (FBS) and Hepes buffer were purchased from Gibco BRL (Basel; Switzerland). Fetuin, transferrin, histidinol, insulin, triiodothyronin, Dex, isobutyl methyl xanthine (IBMX), biotin, D-panthotenic acid, OA were purchased from Sigma (Buchs; Switzerland). NaHCO 3 was obtained from Merck (Darmstadt; Germany).
Recombinant virus preparation
Infectious hTERT recombinant viral particles were generated as previously described. 5 The packaging cell line PA317 transfected with a retroviral construct consisting of the pLXSN vector containing the HPV-E7 gene was kindly provided by Dr. CC Harris (NCI, NIH, Bethesda, USA). Viral particles were obtained through the ping-pong procedure as previously described. 23 
Preparation and infection of human preadipocytes
Adipocyte precursors from subcutaneous abdominal adipose tissue obtained during a gastroplasty surgery of a 33-year-old obese female patient, with a body mass index of 54 Og/m 2 , were prepared as previously described 24 and cultivated in a mix of DMEM/F12 media (v/v) supplemented with 2 mM glutamine, 100 U/ml penicillin/streptamycin and 10% FBS. At 70-80% confluence, primary preadipocytes were incubated for 4 h at 371C and 5% CO 2 with recombinant retrovirus containing the hTERT gene in the presence of 20 mg/ml DEAE dextran. After infection, the culture medium was changed to a mixture of DMEM/ F12 media supplemented with 10% FBS, glutamine and penicillin/streptomycin. After 48 h, 5 mM histidinol was added to the culture medium and viable clones were isolated and expanded. Their ability to differentiate into lipid-filled adipocytes was tested using the Oil-red O staining, as described below. The clone presenting the highest lipid accumulation was grown until passage 8 and infected with a recombinant virus containing the HPV-E7 gene. 
Differentiation of Chub-S7 cells
Cells were grown in a mixture of DMEM/F12 media supplemented with 10% FBS, 2 mM glutamine, 100 U/ml penicillin/streptamycin until confluency. For differentiation, cells were cultured with a serum-free medium consisting of a mixture of DMEM/F12 media supplemented with 15 mM NaHCO 3 , 17 mM D-panthotenic acid, 15 mM Hepes, 33 mM biotin, 10 mg/ml transferrin, 1 nM triiodothyronin, 850 nM insulin and 500 mg/ml fetuin. This medium, referred to as 'basal medium', was supplemented with 1 mM Dex and 500 mM IBMX from day 0 to 3. Dex was maintained alone or with 1 mM BRL49653 from day 3 to 17 in order to promote differentiation. As stated in Results, OA complexed with bovine serum albumin (BSA; ratio OA-to-BSA: 5 : 1) was added to the medium containing BRL49653 from days 10 to 17. Lipid accumulation in differentiated cells was visualized by Oil-red O staining as previously described. 13 All the experiments on Chub-S7 cell characterization were performed between passages 18 and 32 (69-122 PDs).
GPDH activity and lipolysis measurements
GPDH activity measured at different times during the differentiation process of Chub-S7 cells was determined using an enzymatic assay previously described. 13 Lipolysis was determined at day 17 after confluency. Cells were incubated 1 h at 371C and 5% CO 2 with a Krebs-Ringer buffer (5 mM NaH 2 PO 4 ; 1 mM MgSO 4 ; 1 mM CaCl 2 ; 136 mM NaCl; 4.7 mM KCl) supplemented with 20 mM Hepes, 2% BSA, 5 mM glucose and 1 mM isoproterenol as indicated in Results. Glycerol released in the medium was measured using the glycerokinase enzymatic radiometric assay described by Bradley and Kaslow. 25 Telomerase repeat amplification (TRAP) assay 10 6 cells, corresponding to about 100 mg proteins, were homogenated in lysis buffer (10 mM Tris-HCl, pH 7.5, 1 mM MgCl 2 , 1 mM EGTA, 0.5% CHAPS, 10% glycerol). The TRAP reaction was performed using 2 mg of protein extracts as previously described. 5 20 ml of the reaction mixture (50 ml) was loaded on a 10% acrylamide gel for the visualization of telomeric repeat amplifications. To assess the specificity of the RNAdependent enzymatic reactions, extracts inhibited by RNAse or heat treatment were included. For RNAse treatment, protein extracts were incubated with 1 mg RNAse A (Roche Diagnostics, Switzeerland) at 371C for 20 min, and for heat treatment, the homogenates were incubated for 10 min at 851C.
Karyotype analysis
Semiconfluent cultures were sent to the Cell Culture Laboratory (Children's Hospital of Michigan, MI, USA) for karyotyping analysis performed as previously described. 5 
Analysis of adipocyte markers expression
RNAs from Chub-S7 cells cultured from day 0 to 17 were extracted using the NucleoSpin s Total RNA Purification System (Macherey-Nagel, Oensingen Switzerland). Reverse transcription was performed with an input of 10 mg of total RNA using the first strand cDNA synthesis kit for RT-PCR (AMV; Roche Biomedical, Basel, Switzerland) with oligo d(T) 15 as primer. Real-time RT-PCR analyses were performed in a fluorescent temperature cycler (GeneAmp s PCR 5700 Sequence Detection System; Applied Biosystem) according to the recommendations of the manufacturer. Briefly, after initial denaturation at 501C for 2 min and 951C for 10 min, reactions were cycled 40 times using the following parameters for all genes studied: 951C for 15 s, primer annealing and extension at 601C for 1 min. SYBR Green I fluorescence was detected at the end of each cycle to monitor the amount of PCR product formed during that cycle. Primers used for the amplification of cDNAs of interest were synthesized by Mycrosynth (Windisch, Switzerland). The sequence of the forward and reverse primers was, respectively: 0 for the RPL-p0 gene, cycle-to-cycle fluorescence emission was monitored and quantified using the GenAmp software provided by Applied Biosystem. Relative mRNA levels (2 DCt ) were determined by comparing the PCR cycle threshold (Ct) between cells at days 0 and cells at days 6, 10, 13 and 17 after confluency (DCt). At day 0, all the genes studied had a detectable amplification level before the 40 cycles of the real-time PCR, with Ct values significantly lower than the Ct obtained in the absence of cDNA (not shown). The purity of the PCR products was checked by analyzing melting curves. The specificity of the amplification product was verified by performing a PCR under the conditions described above, but during a number of cycles defined according to the linear amplification of the genes (number of cycles for the amplification of adipsin: 23; aP2: 20; C/EBPa: 25; Leptin: 29; LPL: 28; PPARg; 23). The PCR products were subjected to electrophoresis on a 12% acrylamide gel followed by staining with Sybergold (Molecular probes, Leiden, The Netherlands).
Western-blot analysis
Cell homogenates (25 mg) prepared as previously described 26 were electrophoresed and transferred to Immobilon polyvinylidene difluoride membranes (Millipores, Switzerland). Membranes were hybridized with anti-PPARg primary antibody (cat. no. sc-7273, mouse monoclonal IgG, Santa Cruz Biotchnology) or anti-C/EBPa primary antibody (cat. no. sc-61, rabbit polyclonal IgG Santa Cruz Biotechnology) both diluted 1:200, for 4 h at room temperature. Antigen-antibody complexes were detected by incubating immunoblots with secondary antibodies labeled with horseradish peroxidase, and revealed by chemiluminescence (ECL, Western blotting detection system, Amersham Life Science). Owing to an unspecific binding of the C/EBPa primary antibody to an antigen migrating at the same level as the 42 KDa CEBPa isoform, only the 30 KDa isoform was shown in Figure 2b .
Statistical analysis
Statistical comparisons were performed on absolute values by ANOVA.
